Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 vistas
• 08/09/23
0
0
Empotrar
administrator
Suscriptores
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios